Company·Founded 2024·Boston, USA
“Ovelle is developing a new way to produce human eggs from a woman’s own cells”In its own words: ovelle.bio

Research-stage biotechnology company developing in vitro gametogenesis (IVG) to create eggs from a woman’s own cells; SFF's 2025 round recommends $667,000 for its general support.

Show detailsHide details

Received $667k from 1 funder

Checked 25 Oct 2026

Money flows

Where its money came from and where it went. Pick years and what to show; hover a box or ribbon for details, click one to focus it, click the background to see everything.

All grants

1 grant totalling $667k, newest first.

2025 1 grant · $667k
DateFunderAmountPurpose
Sep 2025Survival and Flourishing Fund$667kSFF-2025: General support source